DSN publisher John Kenlon caught up with Stephen Beckman, CEO of Yaral Pharma, to discuss the evolving role of generics in healthcare.

Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. Monday, Viatris and Amphastar Pharmaceuticals both said they have received the FDA’s ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters, seeking to tap into a market that is ...

Novartis cannot block drugmaker MSN Pharmaceuticals from launching a generic version of its blockbuster heart-failure drug Entresto before its patent expires late next year, a Delaware federal ...

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.

Meanwhile, the bloc should also tackle the economic, regulatory and environmental pressures that have made production of generic medicines in Europe less attractive in recent years, Nitka added.

This is why Joe Coulombe—you might know him better as Trader Joe—decided to go all in on his own type of grocery-store-branded products, ones that were cheaper than national brands but had ...

Why the closure of an FDA office may impact generics manufacturers — and everyday Americans.

Savings from biosimilar medicines alone increased to $12.4 billion in 2023 and $36 billion since the first biosimilar entry in 2015, according to AAM's latest report.

What the 2024-election polls say today: Democrats have taken the lead in the generic congressional ballot. But handicappers still give Republicans a good chance to hold the House in November.